Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Vericel

NASDAQ VCEL
$49.41 0.88 1.78%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 26 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

2.38B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
2.30B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.12
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
48.14M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
38.75 %

Upcoming events Vericel

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Vericel

Stock analysis Vericel

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
5,274.16 28.42
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
10.53 4.33
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
2,087.16 9.95
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
-73.28 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
0.19 7.67

Price change Vericel per year

18.09$ 68.94$
Min Max

Summary analysis Vericel

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Vericel

Revenue and net income Vericel

All parameters

Stock news Vericel

All news
10 January 2023 в 20:36

Vericel Shares Up 13% on Preliminary FY22 Revenue Gain, Accelerated MACI Launch

10 January 2023 в 20:36

Vericel Shares Up 13% on Preliminary FY22 Revenue Gain, Accelerated MACI Launch

29 December 2022 в 22:05

MediWound, Vericel Get FDA Approval for NexoBrid Burn Treatment

29 December 2022 в 22:05

MediWound, Vericel Get FDA Approval for NexoBrid Burn Treatment

9 November 2022 в 20:00

Vericel Shares Slide to Two-Year Low After 3Q Report

9 November 2022 в 20:00

Vericel Shares Slide to Two-Year Low After 3Q Report

13 April 2022 в 14:20

Vericel started at buy with $44 stock price target at Truist

About company Vericel

Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product includes, NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Address:
64 Sidney Street, Cambridge, MA, United States, 02139
Company name: Vericel
Issuer ticker: VCEL
ISIN: US92346J1088
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 1997-02-04
Sector: Healthcare
Industry: Biotechnology
Site: https://vcel.com

On which stock exchange are Vericel (VCEL) stocks traded?

Vericel (VCEL) stocks are traded on NASDAQ.

What is the ticker of Vericel stocks (VCEL)?

The stock ticker of Vericel’s stocks or in other words, the code is VCEL. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Vericel (VCEL) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Vericel (VCEL) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Vericel (VCEL) stocks traded?

Vericel (VCEL) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Vericel (VCEL) stocks today?

The current price of Vericel stocks on 16.05.2024 is 49.41 dollars. per share.

What is the dynamics of Vericel (VCEL) stocks from the beginning of the year?

Vericel (VCEL) quotes have increased by 41.66% from the beginning of the year up to 49.41 dollars. per 1 stocks.

How much did Vericel (VCEL) stocks increase in мае 2024?

This month Vericel (VCEL) quotes have increased by 4.95% to 49.41 dollars. per share.

How much are Vericel (VCEL) stocks worth?

Today, on October, 16.05.2024 Vericel’s (VCEL) stocks cost 49.41 dollars..

What is the market capitalization of Vericel (VCEL)?

Capitalization is the market value of Vericel (VCEL) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 16.05.2024, the market capitalization of Vericel (VCEL) is estimated at about 2378646810 dollars.